Հոդերի մագնիսական թերապիա այսօր

Abstrac: Reports and reviews from various sources, including the World Health Organization and United Nations Population Division, confirm the general increasing trend in the ageing population groups worldwide. There are over 150 types of musculoskeletal conditions, with rheumatoid arthritis, osteoarthritis, osteoporosis, low back pain and limb trauma, accounting for the greatest impact on the population at large. Osteoarthritis (OA) is predicted to become the fourth leading cause of disability by the year 2020. The most common medication prescribed for OA is non-steroidal anti-inflammatory drugs (NSAIDs). These have long been associated with numerous adverse effects, are costly and short-term in their ‘therapeutic’ effect. Pulsed Signal Therapy® (PST™) is an innovative treatment modality for musculoskeletal conditions. It has been commercially available since 1992, is currently employed in at least 800 clinics and/or medical institutes, and to-date, no adverse effects have been reported. Furthermore, it is non-invasive, non-pharmacological, painless, with long-term follow-up, and sustained efficacy. When connective tissue is injured and physiological signalling is disturbed or absent, PST™, as the external, biophysical signal (stimulus) of physiological energy parameters and waveform, passively induces ‘fluid flow’ in the injured area, creating ‘streaming potentials’, that induce biophysical-biochemical coupling, subsequent signal transduction, to activate repair and regenerative processes. In doing so, it restores the innate, physiological signalling to enable these regenerative and repair processes to continue naturally.

Pulsed Signal Therapy (PST) is a special therapy with pulsed electromagnetic fields. It produces good results in clinical studies (73% and 87% with high signification). One joint was treated over 9 or 12 days. Osteoarthrosis and sports injuries are the most common indications for PST. Experimental studies on human chondrocytes show a better growth under PST. Other studies point at more synthesis of proteoglycans and hydroxyprolin of human chondrocyte pellets

Abstract. Pulsed Signal Therapy® (PST®) is a unique form of therapy that entails directing a specific physiological signal carried on a series of magnetic field pulses to the treatment site. These uniquely specific energy parameters are transmitted through the injured tissue to target the affected area via direct induction. The corrective PST® signal, carried on the magnetic wave-pulse, induces a tiny electrical signal that mimics the physiological signaling normally occurring in healthy living organisms. In this way, it exerts its therapeutic effects by stimulating cellular repair. Double-blind clinical trials and other open label randomized studies conducted in over 100,000 patients have consistently confirmed the long term efficacy and safety of PST® in patients suffering from osteoarthritis of the knee, cervical and lumbar spine. Data was collected over a 10 year period in the USA, Canada, France, Italy and Germany, by qualified specialists at major medical centers, or their affiliated teaching hospitals and other facilities.* Extensive studies in patients with temporomandibular joint disorder (TMJ) and tinnitus, not responsive to other therapies, have shown significant improvement, following PST®. Ergo PST has been successfully used in the treatment of chronic pain associated with connective tissue (cartilage, tendon, ligaments and bone) injury, osteoarthritis (OA or arthrosis) and also in the treatment of joint-associated soft tissue injury (traumatic, including soft tissue injury). In effect, PST® has been shown to exert positive effects on both cartilage and dense connective tissue, and in stimulating the repair of bone-tissue.